During the past decade, Krankenanstalt Mutterhaus der Borromaerinnen conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 3 clinical trials were completed, i.e. on average, 15% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krankenanstalt Mutterhaus der Borromaerinnen" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials, followed by "University of Ulm" with 5 trials sponsored, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 4 trials sponsored, "German CLL Study Group" with 3 trials sponsored and "University Hospital Schleswig-Holstein" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenanstalt Mutterhaus der Borromaerinnen" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Deutsche Kinderkrebsstiftung" with 2 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator and "Roche Pharma AG" with 2 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Krankenanstalt Mutterhaus der Borromaerinnen" are "Lymphoma" (6 trials), "Acute Myeloid Leukemia" (4 trials), "Leukemia" (4 trials), "Acute Myeloid Leukemia (AML)" (3 trials) and "Breast Cancer" (3 trials). Many other conditions were trialed in "Krankenanstalt Mutterhaus der Borromaerinnen" in a lesser frequency.

Most popular intervention types in "Krankenanstalt Mutterhaus der Borromaerinnen" are "Drug" (47 trials), "Radiation" (16 trials), "Biological" (13 trials), "Procedure" (6 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (12 trials), "cyclophosphamide" (11 trials), "doxorubicin hydrochloride" (10 trials), "vincristine sulfate" (10 trials) and "filgrastim" (7 trials). Other intervention names were less common.

The vast majority of trials in "Krankenanstalt Mutterhaus der Borromaerinnen" are 47 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Krankenanstalt Mutterhaus der Borromaerinnen". undefined are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Krankenanstalt Mutterhaus der Borromaerinnen, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Krankenanstalt Mutterhaus der Borromaerinnen, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Krankenanstalt Mutterhaus der Borromaerinnen has several departments that took part in Clinical trials: "Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie" - 11 trials, "Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I" - 2 trials